Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2017 meeting (3 year revision) are listed below. See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2017.

ATC code	ATC level name (INN/generic name)	DDD	Unit	Adm.route

A01AD02	benzydamide	9	mg	O
A02BC06	dexlansoprazole	30	mg	O
A04AA02	granisetron	3.1	mg	TD
A04AA05	palonosetron	0.5	mg	O
A06AX04	linaclotide	0.29	mg	O
A10BX10	lixisenatide	20	mcg	P
B02BD11	catridecacog	2.5	TU	P
C01EB21	regadenoson	0.4	mg	P
C02KX04	macitentan	10	mg	O
G04BE10	avanafil	0.1	g	O
J01CF06	nafcillin	3	g	P
J05AX12	dolutegravir	50	mg	O
J05AX13	umifenovir	0.8	g	O
J05AX15	sofosbuvir	0.4	g	O
L02BB04	enzalutamide	0.16	g	O
L03AA14	lipegfilgrastim	0.3	mg	P
L03AB14	cepeginterferon alfa-2b	17	mcg	P
L04AA34	alemtuzumab	0.13	mg	P
L04AX06	pomalidomide	3	mg	O
M04AX02	pegloticase	0.57	mg	P
N05AE05	lurasidone	60	mg	O
N05BX04	fabomotizole	30	mg	O
N06AX26	vortioxetine	10	mg	O
N07BB05	nalmefene	18	mg	O
N07XX09	dimethyl fumarate	0.48	g	O
R06AX29	bilastine	20	mg	O

Last updated: 2016-12-20